AGI-16903 is a metabolite of Enasidenib ( HY-18690 ). Enasidenib is an orally available, reversible, and selective inhibitor of mutant IDH2 enzymes , with IC 50 values of 100 nM and 400 nM against IDH2 R140Q and IDH2 R172K , respectively.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Drug Metabolite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye